Kohjin Bio reshaped its governance structure on June 26, using its annual shareholder meeting to approve a move to a company with an audit and supervisory committee and to amend its articles for a two-person representative setup, a representative director and chairman alongside a representative director and president.
The company said the role split is meant to strengthen management, support smooth succession and improve operational flexibility. In a same-day board decision, Takahito Nakamura moved from representative director and president to representative director and chairman, while Yuichi Nakamura, previously senior managing director in charge of sales, became representative director and president, effective June 26.
The AGM also approved a ¥10 per share dividend, ¥51.1mn in total, effective June 29, elected four directors and three directors who will serve on the audit and supervisory committee, and appointed RSM Seiwa Audit Corporation as accounting auditor.
One governance detail still matters in the background. A separate disclosure said Takahito Nakamura remained Kohjin Bio's controlling shareholder as of March 31, with 53.91% of voting rights, including 43.25% held directly and 10.66% indirectly. The company said it had no transactions with the controlling shareholder and that it generally avoids such dealings, with board deliberation and auditor oversight if any are considered.